The efficacy and safety of beinaglutide alone or in combination with insulin glargine in Chinese patients with type 2 diabetes mellitus who are inadequately controlled with oral antihyperglycemic therapy: A multicenter, open‐label, randomized trial
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The efficacy and safety of beinaglutide alone or in combination with insulin glargine in Chinese patients with type 2 diabetes mellitus who are inadequately controlled with oral antihyperglycemic therapy: A multicenter, open‐label, randomized trial
Authors
Keywords
-
Journal
Journal of Diabetes
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-21
DOI
10.1111/1753-0407.13483
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Free Versus Fixed-Ratio Combination of Basal Insulin and GLP-1 Receptor Agonists in Type 2 Diabetes Uncontrolled With GLP-1 Receptor Agonists: A Systematic Review and Indirect Treatment Comparison
- (2022) Han Na Jung et al. Frontiers in Endocrinology
- Liraglutide Hospital Discharge Trial: A Randomized Controlled Trial Comparing the Safety and Efficacy of Liraglutide versus Glargine Insulin for the Management of Patients with Type 2 Diabetes After Hospital Discharge
- (2021) Francisco J Pasquel et al. DIABETES OBESITY & METABOLISM
- Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future
- (2021) Filipe Ferrari et al. American Journal of Cardiovascular Drugs
- Introduction: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- Comparison of Beinaglutide Versus Metformin for Weight Loss in Overweight and Obese Non-diabetic Patients
- (2021) Lijun Gao et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Recombinant human GLP-1 beinaglutide regulates lipid metabolism of adipose tissues in diet-induced obese mice
- (2021) Feng Zhang et al. iScience
- Insights into incretin-based therapies for treatment of diabetic dyslipidemia
- (2020) Kerstin Stemmer et al. ADVANCED DRUG DELIVERY REVIEWS
- Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease
- (2020) Michael C. Honigberg et al. JAMA Cardiology
- C-Peptide Area Under the Curve at Glucagon Stimulation Test Predicts Glucose Improvements by GLP-1 Receptor Analogue: A Retrospective Observational Study
- (2019) Azusa Ohbatake et al. Diabetes Therapy
- Standards of medical care for type 2 diabetes in China‐0027
- (2019) Weiping Jia et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Effect of Once Weekly Dulaglutide versus Insulin Glargine in Patients with Type 2 Diabetes and Different Baseline Glycaemic Patterns: A Post‐Hoc Analysis of the AWARD‐2 Clinical Trial
- (2019) Francesco Giorgino et al. DIABETES OBESITY & METABOLISM
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials
- (2019) Vanita R. Aroda et al. DIABETES OBESITY & METABOLISM
- Meta‐analysis on the efficacy and safety of SGLT2 inhibitors and incretin based agents combination therapy vs. SGLT2i alone or add‐on to metformin in type 2 diabetes
- (2019) Yue Zhou et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETES CARE
- Pathophysiology of Diabetic Dyslipidemia
- (2018) Tsutomu Hirano Journal of Atherosclerosis and Thrombosis
- Glucagon-like peptide-1 receptor agonists reduced the low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus treated with statins
- (2018) Yukiko Hasegawa et al. Journal of Clinical Lipidology
- Glucagon-like peptide-1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis
- (2016) Sonal Singh et al. DIABETES OBESITY & METABOLISM
- Glycemic control and self-monitoring of blood glucose in Chinese patients with type 2 diabetes on insulin: Baseline results from the COMPASS study
- (2016) L Ji et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- New insights into the pathophysiology of dyslipidemia in type 2 diabetes
- (2015) Marja-Riitta Taskinen et al. ATHEROSCLEROSIS
- Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes
- (2015) Angus G. Jones et al. DIABETES CARE
- Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists
- (2015) Sten Madsbad DIABETES OBESITY & METABOLISM
- Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis
- (2014) Conrad Eng et al. LANCET
- Primacy of the 3B Approach to Control Risk Factors for Cardiovascular Disease in Type 2 Diabetes Patients
- (2013) Linong Ji et al. AMERICAN JOURNAL OF MEDICINE
- Cardiovascular Outcomes in Framingham Participants With Diabetes
- (2011) Guanmin Chen et al. HYPERTENSION
- Therapeutics of Diabetes Mellitus: Focus on Insulin Analogues and Insulin Pumps
- (2010) Vasiliki Valla Experimental Diabetes Research
- Hypertension, concurrent cardiovascular risk factors and mortality: the Singapore Cardiovascular Cohort Study
- (2008) J Lee et al. JOURNAL OF HUMAN HYPERTENSION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started